ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

NIH Updates Policy On Large Grants

May 10, 1996

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985